Ionis Pharmaceuticals, Inc. Common Stock (IONS) — Analysis Summary
Ionis Pharmaceuticals, Inc. Common Stock (IONS) has a market cap of $12.64B with year-over-year revenue growth of +33.8%. Net margin stands at -40.4%. The stock trades at a P/E ratio of -38.7.
Key Takeaways
- Revenue changed +33.8% year-over-year
- Net margin of -40.4%
- P/E ratio of -38.7
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, IONS posted revenue growth of +33.8% and trades at a P/E of -38.7.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.